Comparative behavioral, neurochemical and pharmacological activities of dihydropyridine calcium channel activating drugs

S. K. O'Neill, D. W. McKay, N. Campbell, Christopher Triggle, M. Crowley, G. T. Bolger

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The behavioral (deficits in motor function in mice), neurochemical (affinity for mouse brain membrane dihydropyridine receptors, effects on neurotransmitter/metabolite levels in mice) and pharmacologic (effect on the contractile activity of guinea pig ileal longitudinal smooth muscle) properties of the calcium channel activators (±)-BAY K 8644, (±)-202-791 (and their corresponding channel activating and antagonist enantiomers) and CGP-28392 were investigated and compared. The calcium channel activating enantiomers (-)-S-BAY K 8644, (+)-S-202-791 and (±)-BAY K 8644, (±)-202-791 and CGP-28392 produced a dose-dependent impairment of rotarod ability and decreases in motor activity in mice with the following order of potency: (-)-S-BAY K 8644 > (±)-BAY K 8644 >> (+)-S-202-791 > (±)-202-791 = CGP-28392. The calcium channel antagonists (+)-R-BAY K 8644 and (-)-R-202-791 were behaviorally inactive but blocked the behavioral effects of (-)-S-BAY K 8644. The binding of dihydropyridine calcium channel activator and antagonist enantiomers to mouse brain membranes was described by both one and two site models. (-)-S-BAY K 8644, (±)-BAY K 8644, (+)-202-791 and CGP-28392 produced contractions in partially depolarized (15 mM K+) strips of guinea pig ileal longitudinal smooth muscle which differed in the degree of maximum contraction obtained. (+)-R-BAY K 8644 and (-)-R-202-791 inhibited potassium-induced contractions (80 mM K+) in guinea pig ileal longitudinal smooth muscle. Dihydropyridine calcium channel activators produced increases (8-56%) in neurotransmitter metabolites in the striatum but not in the somatosensory cortex of mouse brain. These results indicate that dihydropyridine calcium channel activators of varying structure can, induce behaviors in mice, an ability which resides in the calcium channel activating enantiomer, and bind to dihydropyridine receptors in either a simple or complex manner. As such, dihydropyridine receptors may mediate the behaviors and the brain region-specific changes in neurotransmitter metabolites that occur subsequent to activation of neuronal calcium channels.

Original languageEnglish
Pages (from-to)905-912
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume253
Issue number3
Publication statusPublished - 1990
Externally publishedYes

Fingerprint

CGP 28392
Calcium Channels
Calcium Channel Agonists
Pharmacology
L-Type Calcium Channels
Pharmaceutical Preparations
Smooth Muscle
Neurotransmitter Agents
Guinea Pigs
Aptitude
Brain
Calcium Channel Blockers
Somatosensory Cortex
Membranes
1,4-dihydropyridine
PN 202-791
Potassium
Motor Activity

ASJC Scopus subject areas

  • Pharmacology

Cite this

Comparative behavioral, neurochemical and pharmacological activities of dihydropyridine calcium channel activating drugs. / O'Neill, S. K.; McKay, D. W.; Campbell, N.; Triggle, Christopher; Crowley, M.; Bolger, G. T.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 253, No. 3, 1990, p. 905-912.

Research output: Contribution to journalArticle

@article{a8fee931d2aa4b31aa58472881ce1666,
title = "Comparative behavioral, neurochemical and pharmacological activities of dihydropyridine calcium channel activating drugs",
abstract = "The behavioral (deficits in motor function in mice), neurochemical (affinity for mouse brain membrane dihydropyridine receptors, effects on neurotransmitter/metabolite levels in mice) and pharmacologic (effect on the contractile activity of guinea pig ileal longitudinal smooth muscle) properties of the calcium channel activators (±)-BAY K 8644, (±)-202-791 (and their corresponding channel activating and antagonist enantiomers) and CGP-28392 were investigated and compared. The calcium channel activating enantiomers (-)-S-BAY K 8644, (+)-S-202-791 and (±)-BAY K 8644, (±)-202-791 and CGP-28392 produced a dose-dependent impairment of rotarod ability and decreases in motor activity in mice with the following order of potency: (-)-S-BAY K 8644 > (±)-BAY K 8644 >> (+)-S-202-791 > (±)-202-791 = CGP-28392. The calcium channel antagonists (+)-R-BAY K 8644 and (-)-R-202-791 were behaviorally inactive but blocked the behavioral effects of (-)-S-BAY K 8644. The binding of dihydropyridine calcium channel activator and antagonist enantiomers to mouse brain membranes was described by both one and two site models. (-)-S-BAY K 8644, (±)-BAY K 8644, (+)-202-791 and CGP-28392 produced contractions in partially depolarized (15 mM K+) strips of guinea pig ileal longitudinal smooth muscle which differed in the degree of maximum contraction obtained. (+)-R-BAY K 8644 and (-)-R-202-791 inhibited potassium-induced contractions (80 mM K+) in guinea pig ileal longitudinal smooth muscle. Dihydropyridine calcium channel activators produced increases (8-56{\%}) in neurotransmitter metabolites in the striatum but not in the somatosensory cortex of mouse brain. These results indicate that dihydropyridine calcium channel activators of varying structure can, induce behaviors in mice, an ability which resides in the calcium channel activating enantiomer, and bind to dihydropyridine receptors in either a simple or complex manner. As such, dihydropyridine receptors may mediate the behaviors and the brain region-specific changes in neurotransmitter metabolites that occur subsequent to activation of neuronal calcium channels.",
author = "O'Neill, {S. K.} and McKay, {D. W.} and N. Campbell and Christopher Triggle and M. Crowley and Bolger, {G. T.}",
year = "1990",
language = "English",
volume = "253",
pages = "905--912",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Comparative behavioral, neurochemical and pharmacological activities of dihydropyridine calcium channel activating drugs

AU - O'Neill, S. K.

AU - McKay, D. W.

AU - Campbell, N.

AU - Triggle, Christopher

AU - Crowley, M.

AU - Bolger, G. T.

PY - 1990

Y1 - 1990

N2 - The behavioral (deficits in motor function in mice), neurochemical (affinity for mouse brain membrane dihydropyridine receptors, effects on neurotransmitter/metabolite levels in mice) and pharmacologic (effect on the contractile activity of guinea pig ileal longitudinal smooth muscle) properties of the calcium channel activators (±)-BAY K 8644, (±)-202-791 (and their corresponding channel activating and antagonist enantiomers) and CGP-28392 were investigated and compared. The calcium channel activating enantiomers (-)-S-BAY K 8644, (+)-S-202-791 and (±)-BAY K 8644, (±)-202-791 and CGP-28392 produced a dose-dependent impairment of rotarod ability and decreases in motor activity in mice with the following order of potency: (-)-S-BAY K 8644 > (±)-BAY K 8644 >> (+)-S-202-791 > (±)-202-791 = CGP-28392. The calcium channel antagonists (+)-R-BAY K 8644 and (-)-R-202-791 were behaviorally inactive but blocked the behavioral effects of (-)-S-BAY K 8644. The binding of dihydropyridine calcium channel activator and antagonist enantiomers to mouse brain membranes was described by both one and two site models. (-)-S-BAY K 8644, (±)-BAY K 8644, (+)-202-791 and CGP-28392 produced contractions in partially depolarized (15 mM K+) strips of guinea pig ileal longitudinal smooth muscle which differed in the degree of maximum contraction obtained. (+)-R-BAY K 8644 and (-)-R-202-791 inhibited potassium-induced contractions (80 mM K+) in guinea pig ileal longitudinal smooth muscle. Dihydropyridine calcium channel activators produced increases (8-56%) in neurotransmitter metabolites in the striatum but not in the somatosensory cortex of mouse brain. These results indicate that dihydropyridine calcium channel activators of varying structure can, induce behaviors in mice, an ability which resides in the calcium channel activating enantiomer, and bind to dihydropyridine receptors in either a simple or complex manner. As such, dihydropyridine receptors may mediate the behaviors and the brain region-specific changes in neurotransmitter metabolites that occur subsequent to activation of neuronal calcium channels.

AB - The behavioral (deficits in motor function in mice), neurochemical (affinity for mouse brain membrane dihydropyridine receptors, effects on neurotransmitter/metabolite levels in mice) and pharmacologic (effect on the contractile activity of guinea pig ileal longitudinal smooth muscle) properties of the calcium channel activators (±)-BAY K 8644, (±)-202-791 (and their corresponding channel activating and antagonist enantiomers) and CGP-28392 were investigated and compared. The calcium channel activating enantiomers (-)-S-BAY K 8644, (+)-S-202-791 and (±)-BAY K 8644, (±)-202-791 and CGP-28392 produced a dose-dependent impairment of rotarod ability and decreases in motor activity in mice with the following order of potency: (-)-S-BAY K 8644 > (±)-BAY K 8644 >> (+)-S-202-791 > (±)-202-791 = CGP-28392. The calcium channel antagonists (+)-R-BAY K 8644 and (-)-R-202-791 were behaviorally inactive but blocked the behavioral effects of (-)-S-BAY K 8644. The binding of dihydropyridine calcium channel activator and antagonist enantiomers to mouse brain membranes was described by both one and two site models. (-)-S-BAY K 8644, (±)-BAY K 8644, (+)-202-791 and CGP-28392 produced contractions in partially depolarized (15 mM K+) strips of guinea pig ileal longitudinal smooth muscle which differed in the degree of maximum contraction obtained. (+)-R-BAY K 8644 and (-)-R-202-791 inhibited potassium-induced contractions (80 mM K+) in guinea pig ileal longitudinal smooth muscle. Dihydropyridine calcium channel activators produced increases (8-56%) in neurotransmitter metabolites in the striatum but not in the somatosensory cortex of mouse brain. These results indicate that dihydropyridine calcium channel activators of varying structure can, induce behaviors in mice, an ability which resides in the calcium channel activating enantiomer, and bind to dihydropyridine receptors in either a simple or complex manner. As such, dihydropyridine receptors may mediate the behaviors and the brain region-specific changes in neurotransmitter metabolites that occur subsequent to activation of neuronal calcium channels.

UR - http://www.scopus.com/inward/record.url?scp=0025335253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025335253&partnerID=8YFLogxK

M3 - Article

VL - 253

SP - 905

EP - 912

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -